Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

T Cell Types and Functions

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...

T Cell Activation and Clonal Selection

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Female sex is associated with superior outcomes in patients treated with CD19-directed CAR T-cell therapy for large B-cell lymphoma.

Haematologica·2026

Same author

Autologous and allogeneic haematopoietic cell transplantation in adult patients with Hodgkin lymphoma: recommendations from the EBMT Practice Harmonisation and Guidelines Committee and Lymphoma Working Party.

The Lancet. Haematology·2026

Same author

Reduced-dose post-transplant cyclophosphamide as graft-versus-host disease prophylaxis in matched donor allogeneic stem cell transplantation: a systematic review of efficacy and toxicity.

Transplantation and cellular therapy·2026

Same author

Infections Within 100 Days of Idecabtagene Vicleucel and Impact on Survival for Relapsed/Refractory Multiple Myeloma: A CIBMTR Analysis.

Transplantation and cellular therapy·2026

Same author

MRD-guided de-escalation of TBI conditioning in ALL.

Bone marrow transplantation·2026

Same author

Comparison of Fludarabine Versus Bendamustine as a Lymphodepleting Chemotherapy Prior to CAR-T for Large Cell Lymphoma.

Transplantation and cellular therapy·2026

Search research articles

Related Experiment Video

Updated: Nov 5, 2025

Author Spotlight: Advancing the Detection of Low-Frequency Mutations in Cancer Tissues

Author Spotlight: Advancing the Detection of Low-Frequency Mutations in Cancer Tissues

Published on: August 23, 2024

Enteropathy-Associated T cell Lymphoma.

Zakiah Al Somali¹, Mehdi Hamadani², Mohamed Kharfan-Dabaja³

¹Adult Hematology/HSCT, Oncology Center, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia.

Current Hematologic Malignancy Reports

|May 19, 2021

Summary

Enteropathy-associated T cell lymphoma (EATL) is a rare, aggressive cancer. Early diagnosis, adherence to gluten-free diets for celiac disease patients, and clinical trials are crucial for improved outcomes.

Keywords:

Celiac disease EATL Intestinal lymphoma T cell Lymphoma

More Related Videos

A Three-dimensional Thymic Culture System to Generate Murine Induced Pluripotent Stem Cell-derived Tumor Antigen-specific Thymic Emigrants

A Three-dimensional Thymic Culture System to Generate Murine Induced Pluripotent Stem Cell-derived Tumor Antigen-specific Thymic Emigrants

Published on: August 9, 2019

Author Spotlight: Elucidating the Pathways of TFH Cell Differentiation in Acute LCMV Challenges

Author Spotlight: Elucidating the Pathways of TFH Cell Differentiation in Acute LCMV Challenges

Published on: April 26, 2024

Related Experiment Videos

Last Updated: Nov 5, 2025

Author Spotlight: Advancing the Detection of Low-Frequency Mutations in Cancer Tissues

Author Spotlight: Advancing the Detection of Low-Frequency Mutations in Cancer Tissues

Published on: August 23, 2024

A Three-dimensional Thymic Culture System to Generate Murine Induced Pluripotent Stem Cell-derived Tumor Antigen-specific Thymic Emigrants

A Three-dimensional Thymic Culture System to Generate Murine Induced Pluripotent Stem Cell-derived Tumor Antigen-specific Thymic Emigrants

Published on: August 9, 2019

Author Spotlight: Elucidating the Pathways of TFH Cell Differentiation in Acute LCMV Challenges

Author Spotlight: Elucidating the Pathways of TFH Cell Differentiation in Acute LCMV Challenges

Published on: April 26, 2024

Area of Science:

Hematology
Oncology
Gastroenterology

Background:

Enteropathy-associated T cell lymphoma (EATL) is a rare mature T cell lymphoma with limited literature.
It is primarily associated with celiac disease (CD) and Northern European populations.
EATL accounts for less than 5% of peripheral T cell lymphomas (PTCL).

Purpose of the Study:

To review and summarize current literature on EATL.
To discuss risk factors, pathogenesis, diagnosis, and treatment options for EATL.
To highlight the aggressive nature and poor prognosis of EATL.

Main Methods:

Literature review and synthesis of available research on EATL.
Analysis of risk factors including age, sex, and HLA-DQ2 homozygosity.
Evaluation of diagnostic standards and therapeutic strategies.

Main Results:

EATL has two subtypes, with Type I EATL strongly linked to celiac disease.
Pathogenesis shares features with refractory celiac disease.
Histological diagnosis is the gold standard; EATL has an aggressive course and poor prognosis.

Conclusions:

Current treatments yield poor outcomes; clinical trials are recommended.
Early diagnosis, referral to specialized centers, and new prognostic models are needed.
Prevention through gluten-free diet adherence in CD patients and surveillance is paramount.